Aeglea Biotherapeutics Inc. (AGLE)

Market is closed

Hedge Fund Popularity

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 4,059,894 $9,338 +58% 0.28%
2.
Baker Bros. Advisors

Julian Baker And Felix Baker

3,410,106 $7,843 0.04%
3.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

3,200,593 $7,361 +14% 0.32%
4.
OrbiMed Advisors

Samuel Isaly

2,956,124 $6,799 0.11%
5.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

1,811,425 $4,166 +15% 0.1%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$0.71 28,200 Officer 36,200 2022-06-08 Filing
$2.34 80,079 Officer, Director 550,540 2022-03-16 Filing
$1.86 42,417 Officer, Director 473,461 2022-03-15 Filing
$1.93 67,472 Officer, Director 431,044 2022-03-14 Filing
$2.06 34,777 Officer, Director 363,572 2022-03-11 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.50 5,900 Officer 2,500 2018-09-27 Filing
$9.55 100 Officer 8,400 2018-09-27 Filing
$10.06 19,550 2,175,314 2018-05-11 Filing
$10.13 22,725 2,194,864 2018-05-10 Filing
$10.11 51,230 2,217,589 2018-05-09 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,580 $8,234 0%
2. 2,921,810 $6,719 0%
3. 2,847,689 $6,550 0.63%
4. 2,552,434 $5,871 0%
5. 2,117,323 $4,869 0%
News See All